Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sinphar Pharmaceutical Co., Ltd. (1734:TWSE), powered by AI.
Sinphar Pharmaceutical Co., Ltd. is currently trading at $31.45. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sinphar Pharmaceutical Co., Ltd. on Alpha Lenz.
View Sinphar Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Sinphar Pharmaceutical Co., Ltd.'s ROE is 10.9%. Explore profitability and growth together.”
Ask for details →Sinphar Pharmaceutical Co., Ltd. is a prominent entity in the pharmaceutical industry, renowned for its dedication to the development, manufacture, and distribution of a wide array of medicinal products. The company focuses on producing over-the-counter drugs, ethical medications, and active pharmaceutical ingredients, catering to a diverse healthcare market. Its product range extends to health supplements, adding a holistic approach to public wellness. Sinphar Pharmaceutical's operations are underpinned by robust research and development efforts, emphasizing innovation and quality in therapeutics. The company significantly contributes to the healthcare sector by enhancing treatment efficacy and safety through advanced technologies and rigorous quality controls. With a strong presence in both domestic and international markets, Sinphar Pharmaceutical Co., Ltd. plays a crucial role in meeting the growing demands for effective healthcare solutions. Its commitment to sustainable practices and continuous improvement in drug formulations makes it a vital player in the global pharmaceutical landscape.
“Sinphar Pharmaceutical Co., Ltd.'s ROE is 10.9%. Explore profitability and growth together.”
Ask for details →Sinphar Pharmaceutical Co., Ltd. (ticker: 1734) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 31.45 with a P/E ratio of -x and P/B of -x.
ROE is 10.91% and operating margin is 12.36%. Annual revenue is $3.4B.